C. Palani Palaniappan
About C. Palani Palaniappan
C. Palani Palaniappan serves as the Chief Technology Officer at Epic Sciences in San Diego, California, where he has worked since 2019. He possesses over 20 years of experience in the diagnostics and pharmaceutical industry, with a strong focus on molecular diagnostics and genomics.
Work at Epic Sciences
C. Palani Palaniappan has served as Chief Technology Officer at Epic Sciences since 2019. In this role, he has played a significant part in advancing the company's liquid biopsy technology, which is essential for precision medicine in oncology. His work focuses on integrating single-cell genomic and phenotypic analysis into clinical settings, thereby enhancing personalized treatment strategies. Epic Sciences is based in San Diego, California, and is known for its innovative approaches in the field of cancer diagnostics.
Education and Expertise
C. Palani Palaniappan holds two Doctorates in Philosophy, one from the University of Rochester School of Medicine and Dentistry, where he studied from 1993 to 1998, and another from Northern Illinois University, where he studied from 1989 to 1993. He also earned a Bachelor's degree in business with an emphasis in marketing from Memphis State University. His educational background supports his extensive expertise in molecular diagnostics and genomics, contributing to the development of advanced diagnostic tools.
Background in Biotechnology and Healthcare
C. Palani Palaniappan has over 20 years of experience in the diagnostics and pharmaceutical industry. He has held various leadership roles, including positions at GE Healthcare, Terumo BCT, Life Technologies, and Dey Pharma. His experience encompasses roles such as Senior Scientist, Section Manager, Executive Vice President, and Vice President of R&D. He has a strong track record of transforming scientific research into practical applications that improve patient outcomes, particularly in cancer treatment.
Previous Positions and Contributions
Before his current role at Epic Sciences, C. Palani Palaniappan worked at GE Healthcare as Head of R&D for Molecular Diagnostics and later as Senior Scientist and Section Manager. He also served as Executive Vice President of Innovation and Development at Terumo BCT. His tenure at Life Technologies included two separate periods as Vice President of R&D. Throughout his career, he has contributed to oncology product launches at Pharmacia, now part of Pfizer, and held leadership positions at Sanofi-Synthelabo and Sanofi-Aventis.
Achievements in Oncology and Diagnostics
C. Palani Palaniappan has made significant contributions to the field of oncology through his work in molecular diagnostics. He has been instrumental in advancing technologies that support precision medicine, particularly in cancer treatment. His efforts have included the integration of genomic analysis in clinical settings, which has enhanced personalized treatment strategies. His leadership in innovation and development teams has led to the creation of cutting-edge diagnostic tools that aim to improve patient outcomes.